Author Archive for: EUROIMMUN AG
About EUROIMMUN AG
This author has yet to write their bio.
Entries by EUROIMMUN AG
The new CE-marked SARS-CoV-2 NeutraLISA from EUROIMMUN provides fast and economical determination of the inhibiting effect of anti- SARS-CoV-2 antibodies in patient samples, serving as a surrogate virus neutralisation test.
The new Anti-SARS-CoV-2 QuantiVac ELISA (IgG) from EUROIMMUN provides quantitative detection of IgG antibodies against the viral S1 antigen, including the receptor binding domain. The ELISA is one of the first commercial antibody tests to allow quantification of the antibody concentration in standardised units (BAU/ml) based on the first WHO International Standard for anti-SARS-CoV-2 immunoglobulin […]